| Literature DB >> 30365604 |
Juliana Beust de Lima1, Anderson Donelli da Silveira1, Marco Aurélio Lumertz Saffi1, Márcio Garcia Menezes1, Diogo Silva Piardi1, Leila Denise Cardoso Ramos Ramm1, Maurice Zanini1, Rosane Maria Nery Ricardo Stein1.
Abstract
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a multifactorial syndrome characterized by a limited exercising capacity. High-intensity interval training (HIIT) is an emerging strategy for exercise rehabilitation in different settings. In patients with HFpEF, HIIT subacute effects on endothelial function and blood pressure are still unknown.Entities:
Mesh:
Year: 2018 PMID: 30365604 PMCID: PMC6248251 DOI: 10.5935/abc.20180202
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Study flow diagram.
Participants’ characteristics at baseline
| Characteristic | n = 16 |
|---|---|
| Female | 9 (56%) |
| Age (years) | 59 ± 7 |
| Weight (kg) | 87 ± 28 |
| Height (cm) | 159 ± 10 |
| Body mass index (kg/m2) | 34 ± 7 |
| Waist circumference (cm) | 110 ± 27 |
|
| |
| Active smoker | 2 (12%) |
| Former smoker | 7 (44%) |
|
| |
| II | 12 (75%) |
| III | 4 (25%) |
|
| |
| Hypertension | 16 (100%) |
| Diabetes | 7(44%) |
| Rheumatic disease (gout) | 2 (12%) |
| Atrial fibrillation | 1 (6%) |
| CRF | 4 (25%) |
| AMI | 2 (12%) |
| Stroke | 3 (19%) |
|
| |
| ACEI/ARA | 16 (100%) |
| Beta-blockers | 13 (81%) |
| Diuretics | 13 (81%) |
| Calcium channel blockers | 11 (69%) |
| Statins | 10 (62%) |
| Antiplatelets | 9 (56%) |
| Vasodilators | 7 (44%) |
| Hypoglycemic drugs | 7 (44%) |
Values are described as mean ± standard deviation or absolute frequency (percentage). Former smoker: more than 1 year without smoking; NYHA: New York Heart Association; CRF: chronic renal failure; AMI: acute myocardial infarction; ACEI: angiotensin-converting enzyme inhibitors; ARA: angiotensin receptor antagonists.
Echocardiographic variables
| Variables | n = 16 |
|---|---|
| LVEF (%) | 68 ± 5 |
| E/e’ | 13 ± 4 |
| LAD (cm) | 4.22 ± 0.41 |
| LVESV (ml) | 37.9 ± 9.10 |
| LVEDV (ml) | 124.41 ± 23.24 |
| LVEDVI (ml/m2) | 67.09 ± 6.35 |
| IVST (cm) | 1.15 ± 0.17 |
| PWT (cm) | 1.10 ± 0.19 |
| LVM (g) | 244.35 ± 58 |
| LVMI (g/m2) | 146.2 ± 35.84 |
| LAVI (ml/m2) | 20.81 ± 3.40 |
Values are described as mean ± standard deviation.LVEF: left ventricular ejection fraction; E/e’: early diastolic peak velocity and diastolic peak velocities of the mitral annulus ratio; LAD: left atrium diameter; LVESV: left ventricular end-systolic volume; LVEDV: left ventricular end-diastolic volume; LVEDVI: left ventricular end-diastolic volume indexed to body surface; IVST: interventricular septum thickness; PWT: posterior wall thickness; LVM: left ventricular mass; LVMI: left ventricular mass indexed by body surface; LAVI: left atrial volume indexed to body surface.
Cardiopulmonary exercise testing variables
| Variables | n = 16 |
|---|---|
| VO2 peak (mL.kg-1min-1) | 18.40 ± 3.16 |
| HR max. (bpm) | 125 ± 23 |
| VE/VCO2 slope | 33 ± 6 |
| PET CO2 rest (mmHg) | 33 ± 3 |
| Pulse O2 | 11.36 ± 4.45 |
| R peak | 1.16 ± 0.13 |
Values are described as mean ± standard deviation or median±interquartile range. VO2 peak: peak oxygen consumption; HR max.: maximum heart rate; VE/VCO2 slope: incline of the ventilatory equivalent of carbon dioxide; PET CO2 rest: expired pressure of carbon dioxide; O2 pulse: oxygen pulse; R peak: respiratory quotient.
Exercise protocol variables
| Variables | Moderate intensity | High Intensity |
|---|---|---|
| HR (bpm) | 98 ± 19 | 113 ± 24 |
| BORG | 13 ± 2 | 16 ± 2 |
| Speed (km/h) | 3 ± 0.3 | 4.9 ± 0.8 |
| Incline (%) | 0.9 ± 0.9 | 5.5 ± 1.9 |
Values are described as mean ± standard deviation. HR: heart rate; BORG: scale of perceived exertion.
Figure 2Brachial artery diameter pre- and post-high-intensity interval training session. Data are expressed as mean± standard deviation. Lines represent individual values. Probability value indicates within-group significant differences.
Brachial artery diameters and variations pre- and post-high-intensity interval training session.
| Variables | Pre | Post | p |
|---|---|---|---|
| Brachial artery diameter (mm) | 3.96 ± 0.57 | 4.33 ± 0.69 | < 0.01 |
| Brachial artery diameter post-hyperemia (mm) | 4.19 ± 0.61 | 4.47 ± 0.66 | < 0.05 |
| Absolute FMD (mm) | 0.23 ± 0.20 | 0.13 ± 0.26 | 0.177 |
| Relative FMD (%) | 5.91± 5.20 | 3.55 ± 6.59 | 0.162 |
| Brachial artery diameter pre-NTG (mm) | 4.11 ± 0.65 | 4.16 ± 0.68 | 0.528 |
| Brachial artery diameter post-NTG (mm) | 4.57 ± 0.65 | 4.52 ± 0.64 | 0.541 |
| Absolute NTG (mm) | 0.46 ± 0.17 | 0.35 ± 0.20 | 0.106 |
| Relative NTG (%) | 11.4 ± 4.4 | 9.0 ± 5.37 | 0.117 |
Values are described as mean ± standard deviation. FMD: flow-mediated dilatation; NTG: nitroglycerin.
Figure 3Variation of blood pressure pre- and post-high-intensity interval training session. Data are expressed as mean± standard deviation. Lines represent mean values:.1) pre-assessment of endothelial function; 2) immediately before HIIT session; 3) 5 minutes after HIIT session; 4) 30 minutes after HIIT session. SBP, systolic blood pressure; MBP, mean blood pressure; DBP, diastolic blood pressure. Probability value indicates within-group differences between points 3 and 1, and points 4 and 1 of SBP. *p < 0.05, **p < 0.01.